Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Amgen Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects May 21, 2017 Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough April 17, 2017 Sanofi Appoints Executive Vice President Diabetes & Cardiovascular October 1, 2017
Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough April 17, 2017